CAM
Close Asset Management Portfolio holdings
AUM
$3.42B
This Quarter Return
-15.58%
1 Year Return
+20.4%
3 Year Return
+78.01%
5 Year Return
+124.39%
10 Year Return
–
AUM
$904M
AUM Growth
+$904M
(-27%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
14.4%
Top 10 Holdings %
Top 10 Hldgs %
73.49%
Holding
218
New
–
Increased
90
Reduced
98
Closed
30
Top Buys
| 1 |
American Express
AXP
|
$130M |
| 2 |
Neurocrine Biosciences
NBIX
|
$106M |
| 3 |
Hewlett Packard
HPE
|
$102M |
| 4 |
S&P Global
SPGI
|
$94.9M |
| 5 |
Procter & Gamble
PG
|
$72.9M |
Top Sells
| 1 |
Bank of New York Mellon
BK
|
$99.9M |
| 2 |
Intel
INTC
|
$86.5M |
| 3 |
Microsoft
MSFT
|
$73.7M |
| 4 |
Citigroup
C
|
$65.4M |
| 5 |
Visa
V
|
$58.9M |
Sector Composition
| 1 | Financials | 32.91% |
| 2 | Healthcare | 13.56% |
| 3 | Technology | 12.78% |
| 4 | Materials | 10.83% |
| 5 | Consumer Staples | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
PepsiCo
PEP
$204B
| $14K | ﹤0.01% |
105
-6,990
| -99% | -$932K |
|
152
VeriSign
VRSN
$25.5B
| $14K | ﹤0.01% |
114
-20,671
| -99% | -$2.54M |
|
|
ATVI
153
DELISTED
Activision Blizzard Inc.
ATVI
| $13K | ﹤0.01% |
577
-44,302
| -99% | -$998K |
|
154
American Water Works
AWK
$28B
| $12K | ﹤0.01% |
1,350
+1,225
| +980% | +$10.9K |
|
155
Starbucks
SBUX
$100B
| $12K | ﹤0.01% |
100
-120,423
| -100% | -$14.5M |
|
156
Gilead Sciences
GILD
$140B
| $11K | ﹤0.01% |
115
-8,085
| -99% | -$773K |
|
157
Synchrony
SYF
$28.4B
| $11K | ﹤0.01% |
125
-2,669
| -96% | -$235K |
|
|
GWPH
158
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $10K | ﹤0.01% |
1,000
+233
| +30% | +$2.33K |
|
159
Colgate-Palmolive
CL
$67.9B
| $9K | ﹤0.01% |
275
-56,955
| -100% | -$1.86M |
|
160
RTX Corp
RTX
$212B
| $9K | ﹤0.01% |
1,250
-61,944
| -98% | -$446K |
|
161
SPDR S&P 500 ETF Trust
SPY
$658B
| $9K | ﹤0.01% |
85
-5,930
| -99% | -$628K |
|
162
GE Aerospace
GE
$292B
| $8K | ﹤0.01% |
100
-62,964
| -100% | -$5.04M |
|
163
Kirby Corp
KEX
$5.42B
| $8K | ﹤0.01% |
575
-15,290
| -96% | -$213K |
|
164
NetEase
NTES
$86.2B
| $8K | ﹤0.01% |
150
-350
| -70% | -$18.7K |
|
165
Novo Nordisk
NVO
$251B
| $8K | ﹤0.01% |
200
-925
| -82% | -$37K |
|
166
Power Integrations
POWI
$2.53B
| $8K | ﹤0.01% |
142
+42
| +42% | +$2.37K |
|
|
AVDL
167
Avadel Pharmaceuticals
AVDL
$1.43B
| $7K | ﹤0.01% |
162
-14,838
| -99% | -$641K |
|
168
Freeport-McMoran
FCX
$63.7B
| $7K | ﹤0.01% |
400
-5,600
| -93% | -$98K |
|
169
Coca-Cola
KO
$297B
| $7K | ﹤0.01% |
4,400
+3,775
| +604% | +$6.01K |
|
170
NOV
NOV
$4.94B
| $7K | ﹤0.01% |
100
-12,450
| -99% | -$872K |
|
171
Fiserv
FI
$75.1B
| $6K | ﹤0.01% |
8,000
-644,680
| -99% | -$484K |
|
172
General Dynamics
GD
$87.3B
| $6K | ﹤0.01% |
350
-200
| -36% | -$3.43K |
|
173
Harley-Davidson
HOG
$3.54B
| $6K | ﹤0.01% |
100
-400
| -80% | -$24K |
|
174
Lam Research
LRCX
$127B
| $6K | ﹤0.01% |
2,000
+1,895
| +1,805% | +$5.69K |
|
175
Revvity
RVTY
$10.5B
| $6K | ﹤0.01% |
250
-50
| -17% | -$1.2K |
|